Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain (Q40241920)

18 September 2017

Hepatitis C virus genotype 1b chimeric replicon containing genotype 3 NS5A domain (English)

1 reference

18 September 2017

1 reference

1

Robert E Lanford

1 reference

18 September 2017

Bernadette Guerra

2

1 reference

PubMed ID

16919701

18 September 2017

Helen Lee

series ordinal

3

1 reference

PubMed ID

16919701

18 September 2017

language of work or name

English

0 references

publication date

21 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

355

1 reference

18 September 2017

2

1 reference

18 September 2017

192-202

1 reference

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Mutational analysis of hepatitis C virus nonstructural protein 5A: potential role of differential phosphorylation in RNA replication and identification of a genetically flexible domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Efficient initiation of HCV RNA replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Variability of the nonstructural 5A protein of hepatitis C virus type 3a isolates and relation to interferon sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Comparative Analysis of Anti-Hepatitis C Virus Activity and Gene Expression Mediated by Alpha, Beta, and Gamma Interferons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Hepatocellular carcinoma: recent trends in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Interferon sensitivity determining sequence of the hepatitis C virus genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Evasion of intracellular host defence by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Gene Expression Profiling of the Cellular Transcriptional Network Regulated by Alpha/Beta Interferon and Its Partial Attenuation by the Hepatitis C Virus Nonstructural 5A Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Steatosis in chronic hepatitis C: Association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Replication Studies Using Genotype 1a Subgenomic Hepatitis C Virus Replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Effect of alpha interferon on the hepatitis C virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Infectious cDNA clone of the hepatitis C virus genotype 1 prototype sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Reduction of hepatitis C virus NS5A hyperphosphorylation by selective inhibition of cellular kinases activates viral RNA replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

The NS5A protein of hepatitis C virus is a zinc metalloprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Natural history of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

VISA is an adapter protein required for virus-triggered IFN-beta signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

Replication of Hepatitis C Virus Subgenomes in Nonhepatic Epithelial and Mouse Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.019

10.1016/J.VIROL.2006.07.019

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

16919701